| People | Locations | Statistics |
|---|---|---|
| Naji, M. |
| |
| Motta, Antonella |
| |
| Aletan, Dirar |
| |
| Mohamed, Tarek |
| |
| Ertürk, Emre |
| |
| Taccardi, Nicola |
| |
| Kononenko, Denys |
| |
| Petrov, R. H. | Madrid |
|
| Alshaaer, Mazen | Brussels |
|
| Bih, L. |
| |
| Casati, R. |
| |
| Muller, Hermance |
| |
| Kočí, Jan | Prague |
|
| Šuljagić, Marija |
| |
| Kalteremidou, Kalliopi-Artemi | Brussels |
|
| Azam, Siraj |
| |
| Ospanova, Alyiya |
| |
| Blanpain, Bart |
| |
| Ali, M. A. |
| |
| Popa, V. |
| |
| Rančić, M. |
| |
| Ollier, Nadège |
| |
| Azevedo, Nuno Monteiro |
| |
| Landes, Michael |
| |
| Rignanese, Gian-Marco |
|
Smith, Kilian E. C.
in Cooperation with on an Cooperation-Score of 37%
Topics
Publications (5/5 displayed)
- 2013Baseline Toxic Mixtures of Non-Toxic Chemicalscitations
- 2013The dosing determines mutagenicity of hydrophobic compounds in the Ames II assay with metabolic transformationcitations
- 2011Application of passive dosing to study the biotransformation and biodegradation of hydrophobic
- 2010Controlling and maintaining exposure of hydrophobic organic compounds in aquatic toxicity tests by passive dosingcitations
- 2010Passive Dosing for Producing Defined and Constant Exposure of Hydrophobic Organic Compounds during in Vitro Toxicity Testscitations
Places of action
| Organizations | Location | People |
|---|
document
Application of passive dosing to study the biotransformation and biodegradation of hydrophobic
Abstract
Achieving well-defined and constant dissolved concentrations of hydrophobic compounds is <br/>challenging due to volatilization or sorptive losses. With passive dosing, continual partitioning <br/>into the test medium of compound(s) loaded in a polymer compensates for losses, and provides <br/>defined and constant dissolved concentrations. Passive dosing can be used for studying biotransformation/ <br/>degradation. Here, the polymer HOC reservoir also compensates for losses due <br/>to the bio-transformation/degradation process itself. Furthermore, a large mass of test compound <br/>is introduced so that compound turnover is significant even at low dissolved concentrations thus <br/>facilitating measurement of the relevant endpoint (e.g., metabolic products in biotransformation <br/>or growth in biodegradation). This study details two applications of passive dosing for studying <br/>bio-transformation/degradation. A format has been developed to study the biodegradation of <br/>phenanthrene and fluoranthene by the bacterial strain EPA 505, allowing degradation rates to be <br/>quantified at defined freely dissolved concentrations from mg/L down to ng/L levels. Passive dosing <br/>was also applied for quantifying the mutagenicity of benzo(a)pyrene metabolites produced <br/>after activation by the liver S9 mix in the in vitro Ames II assay. Compared to the case with spiking, <br/>responses from passive dosing were shifted by a factor 100-1000 to lower concentrations, <br/>and were also more reproducible between repeated tests. This difference in apparent sensitivity <br/>cannot solely be explained by partitioning, and is due to slow dissolution kinetics as well as massdepletion <br/>of the spiked benzo(a)pyrene. Therefore, passive dosing is a useful tool for the study of <br/>hydrophobic compound bio-transformation/degradation at well-defined dissolved concentrations <br/>down to very low levels. Important advantages include studying process kinetics at precisely <br/>defined dissolved concentrations and allowing increased compound turnover even at constant <br/>and low concentrations. <br/> <br/>